Ghent University Academic Bibliography

Show Sort by

Your filters: cql: author exact F3FA8394-F0ED-11E1-A9DE-61C894A0A6B4

Add to list
- Journal Article
- A1
Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models

Yves Depetter, Silke Geurs (UGent) , Rob De Vreese (UGent) , Sophie Goethals, Elien Vandoorn (UGent) , Alien Laevens, Jonas Steenbrugge (UGent) , Evelyne Meyer (UGent) , Pascal de Tullio, Marc Bracke (UGent) , et al.

(2019) INTERNATIONAL JOURNAL OF CANCER. 145(3). p.735-747
Add to list
- Conference Paper
- C3
Recombinant extracellular vesicles : biological reference material to standardize extracellular vesicle research

Edward Geeurickx, Elisa Heyrman, Jan Van Deun (UGent) , Lien Lippens (UGent) , Joeri Tulkens, Bert Dhondt (UGent) , Glenn Vergauwen (UGent) , Kris Gevaert (UGent) , Francis Impens (UGent) , Ilkka Miinalainen, et al.

(2018) OncoPoint, 6th Research seminar, Abstracts.
Add to list
- Journal Article
- A1
Heterocellular 3D scaffolds as biomimetic to recapitulate the tumor microenvironment of peritoneal metastases in vitro and in vivo

Emiel De Jaeghere (UGent) , Elly De Vlieghere (UGent) , Jasper Van Hoorick (UGent) , Sandra Van Vlierberghe (UGent) , Glenn Wagemans, Leen Pieters (UGent) , Elodie Melsens (UGent) , Marleen Praet, Jo Van Dorpe (UGent) , Matthieu Boone (UGent) , et al.

(2018) BIOMATERIALS. 158. p.95-105
Add to list
- Journal Article
- A1
Radiotherapy-activated cancer-associated fibroblasts promote tumor progression through paracrine IGF1R activation

Joke Tommelein (UGent) , Elly De Vlieghere (UGent) , Laurine Verset, Elodie Melsens (UGent) , Justine Leenders, Benedicte Descamps (UGent) , Annelies Debucquoy, Christian Vanhove (UGent) , Patrick Pauwels (UGent) , Christian P Gespach, et al.

(2018) CANCER RESEARCH. 78(3). p.659-670
Add to list
- Journal Article
- A2
Nieuwe inzichten betreffende metastasen

Marc Bracke (UGent)

(2018) TIJDSCHRIFT VOOR GENEESKUNDE. 74(19). p.1261-1264
Add to list
- Journal Article
- A1
Glucocorticoids indirectly decrease colon cancer cell proliferation and invasion via effects on cancer-associated fibroblasts

Zuzanna Drebert (UGent) , Elly De Vlieghere (UGent) , Jolien Bridelance (UGent) , Olivier De Wever (UGent) , Karolien De Bosscher (UGent) , Marc Bracke (UGent) and Ilse Beck (UGent)

(2018) EXPERIMENTAL CELL RESEARCH. 362(2). p.332-342
Add to list
- Journal Article
- A1
- open access
Improved synthesis and comparative analysis of the tool properties of new and existing D-ring modified (S)-blebbistatin analogs

Sigrid Verhasselt (UGent) , Bart Roman (UGent) , Marc Bracke (UGent) and Christian Stevens (UGent)

(2017) EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY. 136. p.85-103
Add to list
- Journal Article
- A1
- open access
Insights into the myosin II inhibitory potency of A-ring-modified (S)-blebbistatin analogs

Sigrid Verhasselt (UGent) , Christian Stevens (UGent) , Tom Van den broecke, Marc Bracke (UGent) and Bart Roman (UGent)

(2017) BIOORGANIC & MEDICINAL CHEMISTRY LETTERS. 27(13). p.2986-2989
Add to list
- Journal Article
- A1
- open access
Discovery of (S)-3′-hydroxyblebbistatin and (S)-3′-aminoblebbistatin : polar myosin II inhibitors with superior research tool properties

Sigrid Verhasselt (UGent) , Bart Roman (UGent) , Olivier De Wever (UGent) , Kristof Van Hecke (UGent) , Rik Van Deun (UGent) , Marc Bracke (UGent) and Christian Stevens (UGent)

(2017) ORGANIC & BIOMOLECULAR CHEMISTRY. 15(9). p.2104-2118
Add to list
- Conference Paper
- C3
A JAK3/STAT3 passenger activation in a lapatinib-acquired resistance model of HER2-amplified breast cancer

Mieke Van Bockstal (UGent) , Nadine Van Roy (UGent) , Glenn Vergauwen (UGent) , Kathleen Lambein (UGent) , Veronique Cocquyt (UGent) , Louis Libbrecht, Hannelore Denys (UGent) , Marc Bracke (UGent) and Olivier De Wever (UGent)

(2017) BREAST. 32(suppl. 1). p.S48-S48
Add to list
- Journal Article
- A1
- open access
Colon cancer-derived myofibroblasts increase endothelial cell migration by glucocorticoid-sensitive secretion of a pro-migratory factor

Zuzanna Drebert (UGent) , Mark MacAskill, Dahlia Doughty-Shenton, Karolien De Bosscher (UGent) , Marc Bracke (UGent) , Patrick WF Hadoke and Ilse Beck (UGent)

(2017) VASCULAR PHARMACOLOGY. 89. p.19-30
Add to list
- Journal Article
- A1
- open access
Secretome analysis of breast cancer-associated adipose tissue to identify paracrine regulators of breast cancer growth

Lore Lapeire (UGent) , An Hendrix (UGent) , Evelyne Lecoutere, Mieke Van Bockstal (UGent) , Jo Vandesompele (UGent) , Dawn Maynard, Geert Braems (UGent) , Rudy Van den Broecke (UGent) , Cathérine Müller, Marc Bracke (UGent) , et al.

(2017) ONCOTARGET. 8(29). p.47239-47249
Add to list
- Journal Article
- A1
- open access
ADAM-17/FHL2 colocalisation suggests interaction and role of these proteins in colorectal cancer

Laurine Verset, Joke Tommelein (UGent) , Christine Decaestecker, Elly De Vlieghere (UGent) , Marc Bracke (UGent) , Isabelle Salmon, Olivier De Wever (UGent) and Pieter Demetter

(2017) TUMOR BIOLOGY. 39(3).
Add to list
- Journal Article
- A1
When neighbors talk : colon cancer cell invasion and tumor microenvironment myofibroblasts

Jolien Bridelance (UGent) , Zuzanna Drebert (UGent) , Olivier De Wever (UGent) , Marc Bracke (UGent) and Ilse Beck (UGent)

(2017) CURRENT DRUG TARGETS. 18(8). p.964-982
Add to list
- Conference Paper
- C3
Discovery of novel nonmuscle myosin II inhibitors as chemical tools and antimetastatic therapeutics leads

Sigrid Verhasselt (UGent) , Marc Bracke (UGent) , Christian Stevens (UGent) and Bart Roman (UGent)

(2016) Chemical Research in Flanders, Symposium abstracts.
Add to list
- Journal Article
- A2
- open access
Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments

Nora Sundahl, Dorien Clarisse (UGent) , Marc Bracke (UGent) , Fritz Offner (UGent) , Wim Vanden Berghe (UGent) and Ilse Beck (UGent)

(2016) ONCOSCIENCE. 3(7-8). p.188-202
Add to list
- Journal Article
- A1
Quantitative evaluation of single cell spread on collagen matrices

Elly De Vlieghere (UGent) , Glenn Wagemans, S De Backer, Zuzanna Drebert (UGent) , Joke Tommelein (UGent) , Quentin Rousseau (UGent) , B Weyn, Marleen Van Troys (UGent) , Marc Bracke (UGent) and Olivier De Wever (UGent)

(2016) EXPERIMENTAL CELL RESEARCH. 349(1). p.168-178
Add to list
- Miscellaneous
Radiation-induced collateral damage : impact on metastasis

Lynn Feys (UGent) , Olivier De Wever (UGent) and Marc Bracke (UGent)

(2016) BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 10(3). p.105-107
Add to list
- Conference Paper
- C3
Discovery of novel nonmuscle myosin II inhibitors as antimetastatic therapeutics leads and chemical tools

Sigrid Verhasselt (UGent) , Marc Bracke (UGent) , Christian Stevens (UGent) and Bart Roman (UGent)

(2016) 15th Belgian organic synthesis symposium : book of abstracts.
Add to list
- Conference Paper
- C3
- open access
The effects of quorum sensing peptides on colon cancer cells: implications for the role of the gut microbiome

Yorick Janssens (UGent) , Evelien Wynendaele (UGent) , Frederick Verbeke (UGent) , An Hendrix (UGent) , Olivier De Wever (UGent) , Marc Bracke (UGent) and Bart De Spiegeleer (UGent)

(2016) OncoPoint, 4th Research seminar, Abstracts.

Academic Bibliography

Selective pharmacological inhibitors of HDAC6 reveal biochemical activity but functional tolerance in cancer models

Recombinant extracellular vesicles : biological reference material to standardize extracellular vesicle research

Heterocellular 3D scaffolds as biomimetic to recapitulate the tumor microenvironment of peritoneal metastases in vitro and in vivo

Radiotherapy-activated cancer-associated fibroblasts promote tumor progression through paracrine IGF1R activation

Nieuwe inzichten betreffende metastasen

Glucocorticoids indirectly decrease colon cancer cell proliferation and invasion via effects on cancer-associated fibroblasts

Improved synthesis and comparative analysis of the tool properties of new and existing D-ring modified (S)-blebbistatin analogs

Insights into the myosin II inhibitory potency of A-ring-modified (S)-blebbistatin analogs

Discovery of (S)-3′-hydroxyblebbistatin and (S)-3′-aminoblebbistatin : polar myosin II inhibitors with superior research tool properties

A JAK3/STAT3 passenger activation in a lapatinib-acquired resistance model of HER2-amplified breast cancer

Colon cancer-derived myofibroblasts increase endothelial cell migration by glucocorticoid-sensitive secretion of a pro-migratory factor

Secretome analysis of breast cancer-associated adipose tissue to identify paracrine regulators of breast cancer growth

ADAM-17/FHL2 colocalisation suggests interaction and role of these proteins in colorectal cancer

When neighbors talk : colon cancer cell invasion and tumor microenvironment myofibroblasts

Discovery of novel nonmuscle myosin II inhibitors as chemical tools and antimetastatic therapeutics leads

Selective glucocorticoid receptor-activating adjuvant therapy in cancer treatments

Quantitative evaluation of single cell spread on collagen matrices

Radiation-induced collateral damage : impact on metastasis

Discovery of novel nonmuscle myosin II inhibitors as antimetastatic therapeutics leads and chemical tools

The effects of quorum sensing peptides on colon cancer cells: implications for the role of the gut microbiome

Contents

Support

Contact